Rare diseases
Investigational molecules
Locations
A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
PolandA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
PolandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PolandEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
PolandA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
PolandA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
PolandA study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy
PolandA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
PolandA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
PolandA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
